loading

Seaport Therapeutics Inc Aktie (SPTX) Neueste Nachrichten

pulisher
Oct 01, 2026

Seaport Therapeutics (NASDAQ:SPTX) Shares Gap UpWhat's Next? - MarketBeat

Oct 01, 2026
pulisher
Sep 30, 2026

Seaport Therapeutics (NASDAQ:SPTX) Shares Gap DownHere's What Happened - MarketBeat

Sep 30, 2026
pulisher
Sep 28, 2026

Seaport Therapeutics (NASDAQ:SPTX) Stock Price Down 6.3%Here's What Happened - MarketBeat

Sep 28, 2026
pulisher
Sep 28, 2026

Seaport Therapeutics, Inc. (NASDAQ:SPTX) Stock Has Consensus Target Price of $38.57 - MarketBeat

Sep 28, 2026
pulisher
Sep 28, 2026

Seaport Therapeutics (NASDAQ:SPTX) Now Covered by Raymond James Financial - MarketBeat

Sep 28, 2026
pulisher
Sep 27, 2026

Seaport Therapeutics, Inc. $SPTX Shares Newly Acquired by State Street Corp - MarketBeat

Sep 27, 2026
pulisher
Sep 26, 2026

Seaport Therapeutics Price Target Announced at $46.00/Share by Raymond James - Moomoo

Sep 26, 2026
pulisher
Sep 25, 2026

Raymond James initiates Seaport Therapeutics stock coverage with strong buy on depression drug potential - Investing.com South Africa

Sep 25, 2026
pulisher
Sep 25, 2026

Raymond James Initiates Seaport Therapeutics at Strong Buy - marketscreener.com

Sep 25, 2026
pulisher
Sep 23, 2026

Seaport Therapeutics, Inc. (SPTX) stock price, news, quote and history - Yahoo Finance UK

Sep 23, 2026
pulisher
Sep 23, 2026

SPTX: Pivotal phase II trials for novel neuropsychiatric drugs advance, backed by robust funding - TradingView

Sep 23, 2026
pulisher
Sep 23, 2026

Seaport Therapeutics at TD Cowen summit: pipeline gains momentum By Investing.com - Investing.com Canada

Sep 23, 2026
pulisher
Sep 20, 2026

Seaport Therapeutics, Inc.(NasdaqGS: SPTX) added to S&P Global BMI Index - marketscreener.com

Sep 20, 2026
pulisher
Sep 17, 2026

Seaport Therapeutics, Inc.(NasdaqGS:SPTX) added to Russell Microcap Growth Benchmark Index - marketscreener.com

Sep 17, 2026
pulisher
Sep 17, 2026

Seaport Therapeutics, Inc.(NasdaqGS: SPTX) added to Russell 3000E Growth Benchmark - marketscreener.com

Sep 17, 2026
pulisher
Sep 14, 2026

Seaport Therapeutics to Participate in September Investor Conferences - Business Wire

Sep 14, 2026
pulisher
Sep 14, 2026

The Manufacturers Life Insurance Company Acquires New Stake in Seaport Therapeutics, Inc. $SPTX - MarketBeat

Sep 14, 2026
pulisher
Sep 11, 2026

Analysts Conflicted on These NA Names: SailPoint, Inc. (SAIL) and Seaport Therapeutics, Inc. (SPTX) - theglobeandmail.com

Sep 11, 2026
pulisher
Sep 11, 2026

Analysts Offer Insights on NA Companies: Seaport Therapeutics, Inc. (SPTX), Navan, Inc. Class A (NAVN) and International Business Machines (IBM) - theglobeandmail.com

Sep 11, 2026
pulisher
Sep 10, 2026

Seaport Therapeutics (NASDAQ:SPTX) Stock Price Up 4.6%Should You Buy? - MarketBeat

Sep 10, 2026
pulisher
Sep 10, 2026

HC Wainwright Reaffirms Buy Rating for Seaport Therapeutics (NASDAQ:SPTX) - MarketBeat

Sep 10, 2026
pulisher
Sep 10, 2026

symbol__ Stock Quote Price and Forecast - cnn.com

Sep 10, 2026
pulisher
Sep 09, 2026

PureTech Founded Entity Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo™ in Healthy Volunteers - biospace.com

Sep 09, 2026
pulisher
Sep 09, 2026

Seaport Therapeutics at citigroup’s biopharma back to school summit 2026: platform push - Investing.com Canada

Sep 09, 2026
pulisher
Sep 09, 2026

Seaport Therapeutics reports positive phase 1 trial results - investing.com

Sep 09, 2026
pulisher
Sep 09, 2026

Seaport Therapeutics, Inc.Common Stock (Nasdaq:SPTX) Stock Quote - FinancialContent

Sep 09, 2026
pulisher
Sep 09, 2026

Seaport Therapeutics reports positive phase 1 trial results By Investing.com - Investing.com Canada

Sep 09, 2026
pulisher
Sep 09, 2026

PureTech Says Seaport Therapeutics Reports Positive Phase 1 Driving Trial Results for GlyphAllo - TradingView

Sep 09, 2026
pulisher
Sep 09, 2026

RCSPureTech Health PLCPRTC's SPTX: New Positive Phase 1 GlyphAllo Data - TradingView

Sep 09, 2026
pulisher
Sep 09, 2026

Seaport Therapeutics Says GlyphAllo Shows no Next-Morning Driving Impairment in Phase 1 Trial - marketscreener.com

Sep 09, 2026
pulisher
Sep 09, 2026

Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo™ in Healthy Volunteers - Business Wire

Sep 09, 2026
pulisher
Sep 08, 2026

Citadel Advisors LLC Takes Position in Seaport Therapeutics, Inc. $SPTX - MarketBeat

Sep 08, 2026
pulisher
Sep 03, 2026

Braidwell LP Takes $10.86 Million Position in Seaport Therapeutics, Inc. $SPTX - MarketBeat

Sep 03, 2026
pulisher
Sep 03, 2026

Seaport Therapeutics, Inc. (NASDAQ:SPTX) Given Consensus Rating of "Hold" by Analysts - MarketBeat

Sep 03, 2026
pulisher
Sep 02, 2026

Alyeska Investment Group L.P. Makes New $1.63 Million Investment in Seaport Therapeutics, Inc. $SPTX - MarketBeat

Sep 02, 2026
pulisher
Aug 31, 2026

Seaport Therapeutics, Inc. Common Stock (NASDAQ: SPTX) Stock Price, News & Analysis - kalkine.ca

Aug 31, 2026
pulisher
Aug 31, 2026

Seaport Therapeutics to Present at Citi’s 2026 Biopharma Back to School Conference and Participate in 21st Annual Wells Fargo Healthcare Conference - BioSpace

Aug 31, 2026
pulisher
Aug 28, 2026

Trv Gp Vi LLC Acquires New Shares in Seaport Therapeutics, Inc. $SPTX - MarketBeat

Aug 28, 2026
pulisher
Aug 27, 2026

Seaport Therapeutics (NASDAQ:SPTX) Stock Price Down 5.2%Here's Why - MarketBeat

Aug 27, 2026
pulisher
Aug 26, 2026

Seaport Therapeutics (NASDAQ:SPTX) Now Covered by Analysts at JonesTrading - MarketBeat

Aug 26, 2026
pulisher
Aug 24, 2026

Seaport Therapeutics (NASDAQ:SPTX) Sets New 52-Week HighHere's Why - MarketBeat

Aug 24, 2026
pulisher
Aug 20, 2026

Why Bristol Myers, Johnson & Johnson and More Are Watching Seaport After IPO - 24/7 Wall St.

Aug 20, 2026
pulisher
Aug 20, 2026

Seaport Therapeutics' (SPTX) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Aug 20, 2026
pulisher
Aug 20, 2026

H.C. Wainwright reiterates Seaport Therapeutics stock rating at buy By Investing.com - Investing.com Canada

Aug 20, 2026
pulisher
Aug 20, 2026

Selvaraju Reiterates Buy on Seaport, Citing Differentiated Neuropsychiatry Pipeline and Unchanged $50 Price Target - TipRanks

Aug 20, 2026
pulisher
Aug 19, 2026

Seaport Therapeutics, Inc.: Target Price Consensus and Analysts Recommendations | SPTX | US81221K1088 - marketscreener.com

Aug 19, 2026
pulisher
Aug 18, 2026

Seaport Therapeutics (NASDAQ:SPTX) Reaches New 52-Week HighHere's What Happened - MarketBeat

Aug 18, 2026
pulisher
Aug 14, 2026

Seaport Therapeutics Inc. (SPTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Aug 14, 2026
pulisher
Aug 14, 2026

PureTech Health (SPTX holder) discloses 31.2% Seaport Therapeutics stake - Stock Titan

Aug 14, 2026
$96.90
price up icon 0.05%
$57.16
price down icon 0.82%
$35.72
price up icon 0.62%
$219.72
price down icon 4.96%
ONC ONC
$358.07
price down icon 0.20%
$206.64
price up icon 0.36%
Kapitalisierung:     |  Volumen (24h):